摘要
目的为促进苯二氮卓类药品合理使用提供参考。方法收集整理我院药剂科药品管理数据库和医院信息管理系统中2014年住院患者应用BZD药物的数据,并对用药频度,使用强度进行统计、分析。结果我院AUD值控制较平稳。DDDs值排前2位的苯二氮卓类药品保持不变,分别为氯硝西泮、阿普唑仑。2014年上半年我院苯二氮卓类药品使用DDDs为27956,AUD值为21.63 DDDs/(100人.d),使用人次1637人;2014年下半年使用DDDs为18433,AUD值为13.37 DDDs/(100人.d),使用人次1422人。与上半年比较,各项指标均有所下降。结论开展专项治理工作,可进一步规范苯二氮卓类药物临床应用管理,提高合理用药水平。
Objective To provide reference for clinical rational use of benzodiazepines drugs.Methods The data of hospitalized patients with BZDs in the department of pharmacy drug administration database and hospital information management system in 2014 were collected,and DDDs,AUD were statistically analyzed.Results The AUD of BZDs were kept on the even level.Top 2 in the list of DDDs were Clonzepam and Alprazolam.In the first half of 2014 the usage of DDDs were 27956,the usage of AUD were 21.63 DDDs /(100p/d),1637 people used;in the second half of 2014 DDDs were 18433,the usage of AUD were 13.37 DDDs /(100p/d),1422 people used.Compared with the first half year,all the indexes decreased.Conclusion The development of special rectification could standardize the clinical application and management of BZD and improve rational use of drugs.
出处
《新疆医学》
2016年第7期839-841,共3页
Xinjiang Medical Journal
基金
乌鲁木齐市卫生局级项目(No:201302)